BioCatalyst

SKYE — Skye Bioscience, Inc. catalysts

1 verified catalyst event(s) for Skye Bioscience, Inc. (ticker SKYE). Each is linked to its official source. Verified as of 2026-08-06.

Next verified catalyst

2026-11-20 — Study to Evaluate the Effect on Obesity of QW Nimacimab and QW Nimacimab Co-administered W · official source ↗

Upcoming

DateEventCompanyDrugOfficial source & verification
2026-11-20
in 4mo
ESTIMATED
 READOUT
Study to Evaluate the Effect on Obesity of QW Nimacimab and QW Nimacimab Co-admi
Phase 2 · Obesity
 SKYE Skye Bioscience, Inc. Nimacimab injection, Nimacimab placebo i ClinicalTrials.gov ↗
✓ Source-checked 2026-08-06
Sponsor-projected date — can change
Disclaimer. Bio Catalyst Calendar is a public-events data calendar. Every date is sourced and linked to an official record (ClinicalTrials.gov, FDA / Federal Register, openFDA). It is scheduling and reference data only — NOT investment advice, a recommendation, or a buy/sell signal. Dates set by sponsors and the FDA can change; always confirm against the linked official source.